Dr. Maria Kontoyianni is an Assistant Professor in Medicinal Chemistry, in the School of Pharmacy. She holds a Ph.D. in Computational Chemistry from the University of North Carolina, Chapel Hill, where she worked under the supervision of Professor Phil Bowen. After a post-doctoral fellowship with Professor Terry Lybrand at the University of Washington, she joined ZymoGenetics, where she focused on ligand-based design and homology modeling. She then moved to Research & Development of Fortune 500 companies, such as Johnson & Johnson and Procter & Gamble, assuming positions of greater responsibility focusing on various therapeutic targets in all stages of drug discovery. In her most recent post, she was the Head of Drug Discovery in a small biotechnology firm in the Science Park of Barcelona. She holds seven patents, is the author of several peer-reviewed publications, a Clinical Advisors consultant and an expert evaluator of the European Union large scale (multi-million) grant applications integrating academic and industrial partnerships. She has also served on the Advisory Board of the West Center for Computational Chemistry and Drug Design, University of the Sciences in Philadelphia. Her laboratory focuses on the classification of structural data pertaining to ligand-protein complexes, development of computational tools to better understand ligand recognition by macromolecular targets, and drug discovery approaches to specific disease areas.
Biography Updated on 14 April 2011